Lunai Bioworks Inc. (LNAI) Form 8-K — Nov 12, 2026
Lunai Bioworks voluntarily filed a Form 25 on November 2, 2026 to delist its common stock (LNAI) from Nasdaq, with the delisting expected effective on or about November 12, 2026 and deregistration following 90 days later. In the same filing, CEO David Weinstein signed an Amended and Restated Employment Agreement cutting his base salary from $400,000 to $275,000, making employment at-will and ending it December 28, 2026 unless extended, with no bonus or equity awards absent board approval.
Key figures
- Ceo salary new
- $275,000
- Ceo salary prior
- $400,000
- Waived severance
- approximately $200,000
- Employment end date
- December 28, 2026
- Deferred salary payment
- $28,150.68
- Deregistration effective
- 90 days after November 2, 2026 Form 25 filing
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.